Atazanavir

Details

Files

Generic Name:

Atazanavir

Project Status:

Complete

Therapeutic Area:

HIV infection

Manufacturer:

Bristol Myers Squibb

Brand Name:

Reyataz

Project Line:

Reimbursement Review

Project Number:

SR0002-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

HIV infection

Recommendation Type:

List in a similar manner to other drugs in class

Final Recommendation:

May 27, 2004

Recommendation:

List in a similar manner as drug plans list other protease inhibitors as part of HIV treatment regimens.

Last Updated : December 16, 2003